First-pass extracted concept

Aβ oligomers

Candidate: concept label1 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

amyloid-β oligomers, soluble Aβ oligomers

Evidence Snippets

The supplied review summary states that the review frames Alzheimer disease pathogenesis around amyloid-β (Aβ) toxicity, especially soluble oligomers, synaptic dysfunction, APP/presenilin genetics, and interactions with tau.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2008Journal of Biological ChemistryDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1interaction summarysupports2008Source 1DOI PubMed

The review discusses interaction between Aβ toxicity and tau biology in Alzheimer disease pathogenesis.

Claim 2mechanistic summarysupports2008Source 1DOI PubMed

The review synthesizes evidence that soluble Aβ oligomers impair synaptic plasticity and contribute to synaptic dysfunction.

Claim 3review summarysupports2008Source 1DOI PubMed

The review presents soluble amyloid-β oligomers as central toxic species in Alzheimer disease pathogenesis rather than focusing only on insoluble plaque deposits.